Phase 4 Atrial fibrillation trials recruiting now

All Atrial fibrillation trials, every phase

Other phases for Atrial fibrillation

Phase 4 Atrial fibrillation trials

• AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
  NCT04796714 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
  NCT04432220 · Phase: Phase 4 · Ages: 19 Years to 80 Years · Sex: All (male and female) · 1 location
• Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
  NCT03968393 · Phase: Phase 4 · Ages: 55 Years and older · Sex: All (male and female) · 105 locations
• CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction
  NCT05508256 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
  NCT04642430 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)
  NCT06401616 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF
  NCT07776054 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 2 locations
• Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation
  NCT06187311 · Phase: Phase 4 · Ages: 19 Years to 99 Years · Sex: All (male and female) · 1 location
• Colchicine's Effect on Inflammatory Markers
  NCT07287345 · Phase: Phase 4 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
  NCT06953726 · Phase: Phase 4 · Ages: 65 Years and older · Sex: All (male and female) · 5 locations
• DUTCH Weight Control in Atrial Fibrillation Study
  NCT06184633 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
  NCT04695106 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation
  NCT06528262 · Phase: Phase 4 · Ages: 19 Years to 84 Years · Sex: All (male and female) · 1 location
• Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients
  NCT07173855 · Phase: Phase 4 · Ages: 16 Years and older · Sex: All (male and female) · 6 locations
• Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation
  NCT07273994 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation
  NCT07405671 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
• Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
  NCT06108414 · Phase: Phase 4 · Ages: 70 Years and older · Sex: All (male and female) · 1 location
• Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients
  NCT05829317 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
  NCT05955365 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease
  NCT07753200 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
  NCT07125417 · Phase: Phase 4 · Ages: No age limits stated · Sex: All (male and female) · 21 locations
• Ondansetron for the Management of Atrial Fibrillation
  NCT05844501 · Phase: Phase 4 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 3 locations
• Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure
  NCT03445949 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Perioperative Statins to Prevent AFib After Lung Surgery
  NCT07727681 · Phase: Phase 4 · Ages: 60 Years and older · Sex: All (male and female) · 2 locations
• Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
  NCT02347111 · Phase: Phase 4 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 4 locations
• Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation
  NCT04700826 · Phase: Phase 4 · Ages: 55 Years to 73 Years · Sex: All (male and female) · 1 location
• Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment
  NCT03868150 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation
  NCT06212674 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Stellate Ganglion Block
  NCT06271707 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
  NCT06486792 · Phase: Phase 4 · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule
  NCT07508618 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 5 locations
• The Clinical Outcomes and Therapeutic Effects in Patients With Cardiac Implantable Electronic Device-detected Subclinical and Clinical Atrial Fibrillation.
  NCT07649109 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
  NCT03862859 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery
  NCT06798714 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Vasoactive Drugs in Intensive Care Unit
  NCT02118467 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)
  NCT06402851 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
  NCT07275697 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
  NCT04436978 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.